The Institute for Patient Access (IFPA) review of Medicare data for patients with rheumatoid arthritis (RA), Crohn’s disease or immunodeficiency found that concerns about the negative consequences of non-medical switching are warranted. Specifically, they concluded that non-medical switching can negatively impact patient care and increase healthcare expenses, particularly for RA patients. Read more.
A change of medication in a stable patient for non-medical reasons puts the patient at unnecessary risk, according to the Coalition of State Rheumatology Organizations (CSR0). Absent any medical reason for the switch, the CSRO says patients should be allowed to remain on their current medication as long as they are medically stable. Read more.